Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel J Sheward

Showing results (21-30 of 45) with videos related to

Pageof 5
Sort By:
Nature Communications|April 19, 2023
Vaccination of SARS-CoV-2-infected individuals expands a broad range of clonally diverse affinity-matured B cell lineagesMark Chernyshev, Mrunal Sakharkar, Ruth I Connor, et al.
JCI Insight|November 29, 2022
Longitudinal single-cell analysis of SARS-CoV-2-reactive B cells uncovers persistence of early-formed, antigen-specific clonesLydia Scharf, Hannes Axelsson, Aikaterini Emmanouilidi, et al.
Cell Reports. Medicine|April 12, 2021
SARS-CoV-2 protein subunit vaccination of mice and rhesus macaques elicits potent and durable neutralizing antibody responsesMarco Mandolesi, Daniel J Sheward, Leo Hanke, et al.
Frontiers in Immunology|February 9, 2023
SARS-CoV-2 spike HexaPro formulated in aluminium hydroxide and administered in an accelerated vaccination schedule partially protects Syrian Hamsters against viral challenge despite low neutralizing antibody responsesDennis Christensen, Charlotta Polacek, Daniel J Sheward, et al.
Clinical & Translational Immunology|March 14, 2022
Probabilistic classification of anti-SARS-CoV-2 antibody responses improves seroprevalence estimatesXaquin Castro Dopico, Sandra Muschiol, Nastasiya F Grinberg, et al.
Immunity|December 27, 2022
Immunoglobulin germline gene polymorphisms influence the function of SARS-CoV-2 neutralizing antibodiesPradeepa Pushparaj, Andrea Nicoletto, Daniel J Sheward, et al.
Retrovirology|June 25, 2015
South African HIV-1 subtype C transmitted variants with a specific V2 motif show higher dependence on α4β7 for replicationSimone I Richardson, Elin S Gray, Nonhlanhla N Mkhize, et al.
Nature Communications|January 11, 2022
A bispecific monomeric nanobody induces spike trimer dimers and neutralizes SARS-CoV-2 in vivoLeo Hanke, Hrishikesh Das, Daniel J Sheward, et al.
Cell Reports. Medicine|May 18, 2024
Structural basis of broad SARS-CoV-2 cross-neutralization by affinity-matured public antibodiesDaniel J Sheward, Pradeepa Pushparaj, Hrishikesh Das, et al.
Ebiomedicine|September 10, 2022
Protection against SARS-CoV-2 transmission by a parenteral prime-Intranasal boost vaccine strategyDennis Christensen, Charlotta Polacek, Daniel J Sheward, et al.
Pageof 5

Showing results (21-30 of 45) with videos related to

Sort By:
Pageof 5
Nature Communications|April 19, 2023
Vaccination of SARS-CoV-2-infected individuals expands a broad range of clonally diverse affinity-matured B cell lineagesMark Chernyshev, Mrunal Sakharkar, Ruth I Connor, et al.
JCI Insight|November 29, 2022
Longitudinal single-cell analysis of SARS-CoV-2-reactive B cells uncovers persistence of early-formed, antigen-specific clonesLydia Scharf, Hannes Axelsson, Aikaterini Emmanouilidi, et al.
Cell Reports. Medicine|April 12, 2021
SARS-CoV-2 protein subunit vaccination of mice and rhesus macaques elicits potent and durable neutralizing antibody responsesMarco Mandolesi, Daniel J Sheward, Leo Hanke, et al.
Frontiers in Immunology|February 9, 2023
SARS-CoV-2 spike HexaPro formulated in aluminium hydroxide and administered in an accelerated vaccination schedule partially protects Syrian Hamsters against viral challenge despite low neutralizing antibody responsesDennis Christensen, Charlotta Polacek, Daniel J Sheward, et al.
Clinical & Translational Immunology|March 14, 2022
Probabilistic classification of anti-SARS-CoV-2 antibody responses improves seroprevalence estimatesXaquin Castro Dopico, Sandra Muschiol, Nastasiya F Grinberg, et al.
Immunity|December 27, 2022
Immunoglobulin germline gene polymorphisms influence the function of SARS-CoV-2 neutralizing antibodiesPradeepa Pushparaj, Andrea Nicoletto, Daniel J Sheward, et al.
Retrovirology|June 25, 2015
South African HIV-1 subtype C transmitted variants with a specific V2 motif show higher dependence on α4β7 for replicationSimone I Richardson, Elin S Gray, Nonhlanhla N Mkhize, et al.
Nature Communications|January 11, 2022
A bispecific monomeric nanobody induces spike trimer dimers and neutralizes SARS-CoV-2 in vivoLeo Hanke, Hrishikesh Das, Daniel J Sheward, et al.
Cell Reports. Medicine|May 18, 2024
Structural basis of broad SARS-CoV-2 cross-neutralization by affinity-matured public antibodiesDaniel J Sheward, Pradeepa Pushparaj, Hrishikesh Das, et al.
Ebiomedicine|September 10, 2022
Protection against SARS-CoV-2 transmission by a parenteral prime-Intranasal boost vaccine strategyDennis Christensen, Charlotta Polacek, Daniel J Sheward, et al.
Pageof 5